These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 3931468)

  • 21. Fibrinolytic measurements in type 2 diabetic patients with acute cerebral infarction.
    Mansfield MW; Catto AJ; Carter AM; Grant PJ
    Diabet Med; 1998 Nov; 15(11):953-7. PubMed ID: 9827850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Reduction of the plasma levels of tissue plasminogen activator after infusion of a lipid emulsion in humans.
    Altomare DF; Semeraro N; Colucci M
    JPEN J Parenter Enteral Nutr; 1993; 17(3):274-6. PubMed ID: 8505834
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tissue-type plasminogen activator, plasminogen activator inhibitor, and histidine-rich glycoproteins in stressed human newborns.
    Corrigan JJ; Jeter MA
    Pediatrics; 1992 Jan; 89(1):43-6. PubMed ID: 1728019
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Assessment of Anti-Tissue Type Plasminogen Activator Antibodies in Patients With Prosthetic Heart Valve Thrombosis: The ATA Trial.
    Özkan M; Kalçık M; Gürsoy MO; Öcal L; Griffini S; Karakoyun S; Yesin M; Gündüz S; Astarcıoğlu MA; Bayam E; Cerşit S; Aykan AÇ; Cugno M
    J Cardiovasc Pharmacol Ther; 2016 Jul; 21(4):372-80. PubMed ID: 26657322
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced levels of tissue plasminogen activator and plasminogen activator inhibitor in plasma of patients with familial amyloidotic polyneuropathy.
    Olofsson BO; Nilsson TK
    Haemostasis; 1990; 20(1):31-6. PubMed ID: 2108913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Reducing the risk of oral contraceptive-induced thrombosis.
    Pizzo SV
    Drug Ther (NY); 1981 Sep; 11(9):101-8. PubMed ID: 12263495
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fibrinolytic activity and d-dimer levels in Behçet's syndrome.
    Yurdakul S; Hekim N; Soysal T; Fresko I; Bavunoglu I; Ozbakir F; Tabak F; Melikoglu M; Hamuryudan V; Yazici H
    Clin Exp Rheumatol; 2005; 23(4 Suppl 38):S53-8. PubMed ID: 16273765
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased plasminogen activator inhibitor and tissue plasminogen activator levels in subjects with electrocardiographic abnormality indicative of ischaemic heart disease: a cross-sectional study in Norsjö, Sweden.
    Hellsten G; Boman K; Bjerle P; Blom P; Nilsson TK
    Eur Heart J; 1992 Jan; 13(1):57-60. PubMed ID: 1577032
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Normal tissue plasminogen activator and plasminogen activator inhibitor activity in plasma from patients with type 1 diabetes mellitus.
    Vicari AM; Viganó D'Angelo S; Testa S; Comi G; Galardi G; Orsi E; D'Angelo A
    Horm Metab Res; 1992 Nov; 24(11):516-9. PubMed ID: 1452117
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pregnancy-induced changes in the fibrinolytic balance: evidence for defective release of tissue plasminogen activator and increased levels of the fast-acting tissue plasminogen activator inhibitor.
    Gore M; Eldon S; Trofatter KF; Soong SJ; Pizzo SV
    Am J Obstet Gynecol; 1987 Mar; 156(3):674-80. PubMed ID: 3493696
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The role of type-1 plasminogen activator inhibitor in failure of thrombolytic therapy with recombinant tissue plasminogen activator.
    Huber K; Beckmann R; Rauscha F; Probst P; Kaindl F; Binder BR
    Z Kardiol; 1993; 82 Suppl 2():195-200. PubMed ID: 8328203
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tissue plasminogen activator and plasminogen activator inhibitor status in Budd-Chiari syndrome.
    Dayal S; Pati HP; Sharma MP
    Haemostasis; 1996; 26(5):284-7. PubMed ID: 8894659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High plasminogen activator inhibitor and tissue plasminogen activator levels in plasma precede a first acute myocardial infarction in both men and women: evidence for the fibrinolytic system as an independent primary risk factor.
    Thögersen AM; Jansson JH; Boman K; Nilsson TK; Weinehall L; Huhtasaari F; Hallmans G
    Circulation; 1998 Nov; 98(21):2241-7. PubMed ID: 9826309
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hypobetalipoproteinemia is associated with low levels of hemostatic risk factors in the Framingham offspring population.
    Welty FK; Mittleman MA; Wilson PW; Sutherland PA; Matheney TH; Lipinska I; Muller JE; Levy D; Tofler GH
    Circulation; 1997 Feb; 95(4):825-30. PubMed ID: 9054738
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Altered plasma fibrin clot properties in essential thrombocythemia.
    Małecki R; Gacka M; Kuliszkiewicz-Janus M; Jakobsche-Policht U; Kwiatkowski J; Adamiec R; Undas A
    Platelets; 2016; 27(2):110-6. PubMed ID: 25989112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tissue plasminogen activator and other risk factors as predictors of cardiovascular events in patients with severe angina pectoris.
    Jansson JH; Nilsson TK; Olofsson BO
    Eur Heart J; 1991 Feb; 12(2):157-61. PubMed ID: 1904350
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Disorders of the liberation of tissue-type plasminogen activator (t-PA) from the venous wall as a cause for recurrent thromboses].
    Hach-Wunderle V; Scharrer I
    Vasa Suppl; 1993; 39():5-10. PubMed ID: 8322122
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Safety of Computed Tomographic Angiography in the Evaluation of Patients With Acute Stroke: A Single-Center Experience.
    Ehrlich ME; Turner HL; Currie LJ; Wintermark M; Worrall BB; Southerland AM
    Stroke; 2016 Aug; 47(8):2045-50. PubMed ID: 27364528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Recombinant tissue plasminogen activator.
    Bell SG
    Neonatal Netw; 1996 Sep; 15(6):13-8. PubMed ID: 8932068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effective treatment with a new protocol using tissue-type plasminogen activator thrombolysis for pump thrombosis with the HVAD device.
    Schrage B; Grahn H; Wagner FM; Bernhardt A; Rybczynski M; Blankenberg S; Reichenspurner H; Barten MJ
    Eur Heart J Acute Cardiovasc Care; 2018 Dec; 7(8):766-770. PubMed ID: 28058856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.